Join this session dedicated to "Advancing Percutaneous Coronary Intervention for Chronic Total Occlusion". Explore the latest advances, evidence-based practices and transformative techniques that leverage intracoronary imaging to improve decision-making in percutaneous coronary intervention for chronic total occlusion. Be inspired by leading experts and collaborate with other...

Explore the intricacies of tricuspid and pulmonary valve disorders, as we delve into the challenges faced by the right heart in this session: discover the groundbreaking approach of triple percutaneous valvular therapy in patient with congenital heart disease, learn about innovative strategies for managing massive atrial...

Consult this session to find out more about common iliac CTO PTA via radial approach, transbrachial intervention of bilateral common iliac arteries, shifting of thrombus across the aortoiliac bifurcation during iliac stenting, and much more!

In this interview, Chiara De Biase and Jean Marco embark on a journey through the history of interventional medicine, focusing on Charles Dotter, the pioneer of transluminal angioplasty, and Andreas Grüntzig.

In this first episode, they discuss Dotter's groundbreaking contributions, including the first interventional transluminal angioplasty in 1964, which revolutionized...

The novel sirolimus-eluting ultra-high molecular weight APTITUDE bioreabsorbable vascular scaffold (BRS) displays higher mechanical strength, expansion capabilities and resistance to fracture compared to other BRS technologies. RENASCENT II is a prospective, multicentre first-in-human clinical study evaluating the clinical performance of the APTITUDE BRS in the treatment...

This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...